Predictive Effect of Systemic Immune-Inflammation Index on Immunotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Predictive Effect of Systemic Immune-Inflammation Index on Immunotherapy in Patients With Advanced Non-Small Cell Lung Cancer

Introduction The platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) are emerging biomarkers for predicting outcomes in lung cancer. However, their prognostic value in advanced non-small cell lung cancer (NSCLC) patients receiving an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fubin Feng MD, Mengxuan Sun MM, Yan Yao MD, Chundi Gao MD, Jing Zhuang MD, Changgang Sun MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-06-01
Series:	Cancer Control
Online Access:	https://doi.org/10.1177/10732748251357465
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Which Types of Patients With Extensive-Stage Small Cell Lung Cancer Benefit From Radiotherapy? A Retrospective Study Integrating Machine Learning With the SEER Database and a Chinese Cohort
by: Haojun Wang MM, et al.
Published: (2025-05-01)

Immunotherapy for Limited-Stage Small Cell Lung Cancer: Innovative Treatments and Future Perspectives
by: Xiaoni Jin MM, et al.
Published: (2025-04-01)

CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC
by: Antoine Desilets, MD, MSc, et al.
Published: (2024-12-01)

Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation
by: Erkan Topkan MD, et al.
Published: (2025-01-01)

Prognostic Effect of pan-Immune-Inflammation Value Indices in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Yan Liu MM, et al.
Published: (2025-05-01)

Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01)

Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation
by: Enes Ucgul MD
Published: (2025-02-01)

Survival Outcomes of Lung Adenocarcinoma With Intestinal Differentiation in the Era of Immunotherapy
by: Micah Tratt, BA, et al.
Published: (2025-07-01)

Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study
by: Yi Peng MD, et al.
Published: (2025-01-01)

Advances in biomarkers for immunotherapy in small-cell lung cancer
by: Hui Li, et al.
Published: (2024-12-01)

The systemic inflammation response index (SIRI) predicts survival in advanced non-small cell lung cancer patients undergoing immunotherapy and the construction of a nomogram model
by: Chunhan Tang, et al.
Published: (2024-12-01)

Application of microwave surgical instrument to lung segmentectomy for small-sized lung cancerCentral MessagePerspective
by: Takeshi Mimura, MD, PhD, et al.
Published: (2024-04-01)

Research Hotspots and Trends of NK Cell Immunotherapy for Acute Myeloid Leukemia: A Bibliometric Analysis From 2000 to 2023
by: Shupeng Chen MD, et al.
Published: (2024-12-01)

Advances and Future Perspectives of HER2 Mutations in Non-Small Lung Cancer (NSCLC), Especially in China
by: Chang Liu MS, et al.
Published: (2025-05-01)

Prognostic value of systemic immune-inflammation index in patients with small-cell lung cancer treated with immune checkpoint inhibitors
by: Yusuke Hamakawa, et al.
Published: (2025-01-01)

Immunotherapy of small cell lung cancer based on prognostic nutritional index
by: Xinling Zhang, et al.
Published: (2025-05-01)

A review of enhanced biosignature immunotherapy tools for predicting lung cancer immune phenotypes using deep learning
by: A. Sheryl Oliver, et al.
Published: (2025-05-01)

Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer
by: Emily Wolf, et al.
Published: (2025-01-01)

Advanced lung cancer inflammation index is associated with mortality in critically ill patients with heart failure
by: Xiaoqian Sun, et al.
Published: (2025-02-01)

T cell immune senescence is associated with frailty and sarcopenia in lung transplant candidates
by: Joanna M. Schaenman, MD, PhD, et al.
Published: (2025-02-01)

Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLC
by: Omar Elghawy, MD, et al.
Published: (2025-09-01)

Prognostic and Predictive Value of Pan-Immune Inflammation Value in Rectal Cancer Patients Treated With Neoadjuvant Therapy
by: Aybala Nur Ucgul MD, et al.
Published: (2025-07-01)

Nutritional status and systemic inflammation in COPD: prognostic value of the advanced lung cancer inflammation index
by: Jun Yao, et al.
Published: (2025-04-01)

Letter to the Editor: EGFR-TKIs Combined with Allogeneic CD8+ NKT Cell Immunotherapy to Treat Patients with Advanced EGFR-Mutated Lung Cancer
by: Hinpetch Daungsupawong PhD, et al.
Published: (2024-10-01)

Prognostic value of the systemic immune-inflammation index in non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
by: Guorong Chen, et al.
Published: (2025-05-01)

Social Vulnerability Index Is Associated With Major Morbidity After Lung Resection
by: Savan K. Shah, MD, et al.
Published: (2025-03-01)

Advances in Immunotherapy of KRAS-mutated Non-small Cell Lung Cancer
by: Xinyue YANG, et al.
Published: (2025-05-01)

First-line immunotherapy in advanced non-small-cell lung cancer
by: Vanita Noronha, et al.
Published: (2019-01-01)

Impact of Hypothermic Perfusion on Immune Responses and Sterile Inflammation in a Preclinical Model of Pancreatic Transplantation
by: Benoit Mesnard, MD, et al.
Published: (2025-01-01)

Commentary: A novel approach for localization of small lung nodulesCentral Message
by: Whitney S. Brandt, MD, et al.
Published: (2020-12-01)

Pituitary enlargement and hypopituitarism in patient with lung cancer treated with immune checkpoint inhibitors: Metastasis or hypophysitis? Role of imaging
by: Pier Paolo Arcuri, MD, et al.
Published: (2025-04-01)

Robotic left apicoposterior bisegmentectomy for non–small cell lung cancerCentral Message
by: William D. Kim, MD, et al.
Published: (2023-04-01)

Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
by: Mitchell S. von Itzstein, MD, et al.
Published: (2025-01-01)

Continuous immunotherapy beyond disease progression in patients with advanced non-small cell and small cell lung cancer
by: Jing Cheng, et al.
Published: (2025-02-01)

Durvalumab-induced organizing pneumonia in extensive-stage small cell lung cancer: A case report and literature review
by: Guoxin Wang, MD, et al.
Published: (2025-05-01)

Real-world efficacy of sublingual immunotherapy with Japanese cedar pollen for cypress pollinosis
by: Aiko Oka, MD, et al.
Published: (2025-08-01)

Nicolau syndrome: A case of ischemic necrosis after subcutaneous immunotherapy
by: Joyce Kim, MD, et al.
Published: (2025-02-01)

Inflammatory markers predict efficacy of immunotherapy in advanced non-small cell lung cancer: a preliminary exploratory study
by: Yingqing Zhang, et al.
Published: (2025-01-01)

The integrated single-cell analysis interpret the lactate metabolism-driven immune suppression in triple-negative breast cancer
by: Xinhai Gao, et al.
Published: (2025-05-01)

Advances in Radiotherapy for Extensive-stage Small Cell Lung Cancer  in the Era of Immunotherapy
by: Tingting CHEN, et al.
Published: (2025-05-01)